Summary
Datamonitor's Novo Nordisk A/S - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Novo Nordisk is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products and offers services to patients, the medical profession and society. The company primarily operates in Europe and North America. The company is headquartered in Bagsvaerd, Denmark and employs about 25,200 people. The company recorded revenues of DKK41,831 million (approximately $7,696.5 million) during the fiscal year ended December 2007, an increase of 8% over 2006. The operating profit of the company was DKK8,942 million (approximately $1,645.2 million) during fiscal year 2007, a decrease of 1.9% over 2006. The net profit was DKK8,522 million (approximately $1,568 million) in fiscal year 2007, an increase of 32.1% over 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available.
|
